BIOMARKERS OF ANEMIC RETINOPATHY: CURRENT OPPORTUNITIES AND PERSPECTIVES
Scientific and Innovative Therapy · 2025
DOI: 10.64582/ivit.uz.250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific and Innovative Therapy, 2025. Verfasst von Sergey Yanchenko und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Anemic retinopathy (AR) occurs in various types of anemia such as iron deficiency, β-thalassemia, and aplastic anemia. Although patients with AR often lack obvious visual complaints, optical coherence tomography (OCT) and OCT angiography (OCTA) can detect early morphometric and functional retinal changes. This article reviews the diagnostic and prognostic value of AR biomarkers and discusses the perspectives of early detection and monitoring.
Zitieren
APA
Yanchenko, S., Odilova, G., & Saidova, N. (2025). BIOMARKERS OF ANEMIC RETINOPATHY: CURRENT OPPORTUNITIES AND PERSPECTIVES. Scientific and Innovative Therapy. https://doi.org/10.64582/ivit.uz.250
Vancouver
Yanchenko S, Odilova G, Saidova N. BIOMARKERS OF ANEMIC RETINOPATHY: CURRENT OPPORTUNITIES AND PERSPECTIVES. Scientific and Innovative Therapy. 2025. doi:10.64582/ivit.uz.250
BibTeX
@article{Yanchenko2025,
author = {Yanchenko, Sergey and Odilova, Guljamol and Saidova, Nigora},
title = {BIOMARKERS OF ANEMIC RETINOPATHY: CURRENT OPPORTUNITIES AND PERSPECTIVES},
journal = {Scientific and Innovative Therapy},
year = {2025},
doi = {10.64582/ivit.uz.250}
}
EUVIMED